Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 8 contracts
Sources: Preferred Stock Warrant Agreement (Allos Therapeutics Inc), Warrant Agreement (Allos Therapeutics Inc), Preferred Stock Warrant Agreement (Allos Therapeutics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Allogene Therapeutics, Inc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 6 contracts
Sources: Preferred Stock Warrant Agreement (Allogene Therapeutics, Inc.), Common Stock Warrant Agreement (Allogene Therapeutics, Inc.), Warrant Agreement (Allogene Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Therapeutics, Aptevo Therapeutics Inc., ▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 6 contracts
Sources: Preferred Stock Warrant Agreement (Aptevo Therapeutics Inc.), Common Stock Warrant Agreement (Aptevo Therapeutics Inc.), Warrant Agreement (Aptevo Therapeutics Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Trius Therapeutics, Inc., 6310 ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 5 contracts
Sources: Warrant Agreement (Trius Therapeutics Inc), Warrant Agreement (Trius Therapeutics Inc), Warrant Agreement (Trius Therapeutics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [•], Attention: [•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Design Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇, ▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary [•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 4 contracts
Sources: Preferred Stock Warrant Agreement (Design Therapeutics, Inc.), Common Stock Warrant Agreement (Design Therapeutics, Inc.), Warrant Agreement (Design Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Marker Therapeutics, Inc., 3▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 4 contracts
Sources: Preferred Stock Warrant Agreement (Marker Therapeutics, Inc.), Debt Securities Warrant Agreement (Marker Therapeutics, Inc.), Preferred Stock Warrant Agreement (Marker Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Revance Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Common Stock Warrant Agreement (Revance Therapeutics, Inc.), Preferred Stock Warrant Agreement (Revance Therapeutics, Inc.), Warrant Agreement (Revance Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos TherapeuticsPernix Therapeutics Holdings, Inc., ▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Common Stock Warrant Agreement (Pernix Therapeutics Holdings, Inc.), Preferred Stock Warrant Agreement (Pernix Therapeutics Holdings, Inc.), Warrant Agreement (Pernix Therapeutics Holdings, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Revance Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 3 contracts
Sources: Common Stock Warrant Agreement (Revance Therapeutics, Inc.), Preferred Stock Warrant Agreement (Revance Therapeutics, Inc.), Warrant Agreement (Revance Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: , and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Warrant Agreement (Allos Therapeutics Inc), Warrant Agreement (Allos Therapeutics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to to, Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Warrant Agreement (Allos Therapeutics Inc), Common Stock Warrant Agreement (Allos Therapeutics Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [•], Attention: [•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Revance Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Warrant Agreement (Revance Therapeutics, Inc.), Preferred Stock Warrant Agreement (Revance Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Marker Therapeutics, Inc., 3▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 2 contracts
Sources: Common Stock Warrant Agreement (Marker Therapeutics, Inc.), Common Stock Warrant Agreement (Marker Therapeutics, Inc.)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , , Attention: , and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Revance Therapeutics, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos TherapeuticsClinical Data, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary Legal Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Debt Securities Warrant Agreement (Clinical Data Inc)
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos TherapeuticsClinical Data, Inc., ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇ Attention: Corporate Secretary Chief Legal Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allos Gain Therapeutics, Inc., ▇▇4▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Corporate Secretary [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).
Appears in 1 contract
Sources: Debt Securities Warrant Agreement (Gain Therapeutics, Inc.)